Efficacy of modified thoraco-laparoscopic Ivor-Lewis versus traditional thoraco-laparoscopic Ivor-Lewis for esophageal cancer: Propensity score-matched analysis.
Ivor-Lewis
esophageal cancer
modified
propensity score matching analysis
thoraco-laparoscopy
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2022
2022
Historique:
received:
21
10
2022
accepted:
29
12
2022
entrez:
3
2
2023
pubmed:
4
2
2023
medline:
4
2
2023
Statut:
epublish
Résumé
To compare the clinical results of the modified Ivor-Lewis procedure, which preserves the azygous vein, thoracic duct and surrounding tissues, with the traditional Ivor-Lewis procedure, which removes these tissues, for treating esophageal squamous cell carcinoma, and evaluating whether the azygous vein, thoracic duct and surrounding tissues are required to be removed for the surgery of esophageal cancer. To retrospectively analyze the clinical data of patients suffering from esophageal cancer treated by thoracic-laparoscopic Ivor-Lewis procedure admitted to the Department of Thoracic Surgery of Gansu Provincial People's Hospital from September 2017 to September 2019. According to the surgical method, they were divided into the modified thoracolaparoscopic Ivor-Lewis (modified group) and the traditional thoracolaparoscopic Ivor-Lewis (traditional group). Propensity score matching analysis (PSM) was applied to reduce the selection bias of confounding factors. A total of 245 patients who suffered from esophageal cancer and underwent thoracic-laparoscopic Ivor-Lewis were enrolled in the study. There were 124 cases in the modified group and 121 cases in the traditional group. The discrepancies in the age and T-stage among patients in the traditional and modified groups were statistically significant. After PSM, the above-mentioned factors became statistically insignificant. There were 86 patients in each group after PSM. Compared with the traditional group, the modified group has shorter operative time ( The modified Ivor-Lewis procedure, which preserves the azygous vein, thoracic duct, and surrounding tissue, reduces surgical trauma in esophageal cancer, has not increased postoperative recurrent metastases, while achieved the same long-term outcomes as expanded surgery.
Identifiants
pubmed: 36733352
doi: 10.3389/fonc.2022.1076014
pmc: PMC9886890
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1076014Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright © 2023 Hong, Gou, Lu, Wu, Sheng, Cui, Bai, Jin and Gou.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Cardiothorac Surg. 2021 Dec 6;16(1):347
pubmed: 34872562
Ann Thorac Surg. 1987 Aug;44(2):119-22
pubmed: 3619535
ANZ J Surg. 2016 Apr;86(4):274-9
pubmed: 25962993
J Surg Oncol. 2016 Dec;114(7):838-847
pubmed: 27569043
Gan To Kagaku Ryoho. 2003 Jul;30(7):923-8
pubmed: 12894705
Cancer Med. 2020 Sep;9(18):6875-6887
pubmed: 32750217
Eur J Surg Oncol. 2022 Mar;48(3):473-481
pubmed: 34955315
J Gastrointest Surg. 2019 Feb;23(2):225-231
pubmed: 30298418
Front Public Health. 2022 Sep 06;10:952087
pubmed: 36148334
Dis Esophagus. 2017 May 1;30(5):1-5
pubmed: 28375449
Ann Surg. 2017 Mar;265(3):481-491
pubmed: 27429017
BMC Surg. 2021 Dec 20;21(1):431
pubmed: 34930248
J Thorac Dis. 2020 Dec;12(12):7337-7345
pubmed: 33447423
Thorac Cancer. 2015 May;6(3):296-302
pubmed: 26273375
World J Surg. 2010 Apr;34(4):738-43
pubmed: 20098986